Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes

被引:15
作者
Allen, DN
Anastasiou, A
Goldstein, G
Gilbertson, M
van Kammen, DP
机构
[1] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA
[2] VA Pittsburgh Healthcare Syst, Highland Dr Div, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] VA Med Ctr, Manchester, NH USA
[5] Robert Wood Johnson Pharmaceut Res Inst, Raritan, NJ USA
关键词
schizophrenia; frontal lobes; neuropsychology;
D O I
10.1016/S0165-1781(00)00112-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The aim of the study was to examine effects of haloperidol on the relationships between neuropsychological measures of frontal lobe functioning and the schizophrenia syndromes of psychomotor poverty and disorganization. Twenty-one participants with schizophrenia were initially evaluated when clinically stable and chronically treated with haloperidol, and 19 were evaluated again after a 3-week haloperidol-free period. Participants were evaluated with the Trail Making Test, the Wisconsin Card Sorting Test, the Purdue Pegboard, and psychiatric rating scales at each evaluation. There were significant correlations between schizophrenia syndromes and the tests sensitive to frontal lobe function when participants were medicated but not when drug-free. No significant changes in symptom severity or motor function occurred from the medication to the medication-free evaluation. The results indicate that haloperidol mediates the relationship between tests sensitive to frontal lobe function and the schizophrenia syndromes of psychomotor poverty and disorganization. This mediation effect was not attributable to changes in overall symptom severity or motor function. (C) 2000 Elsevier Science ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 22 条
  • [1] Andreasen NC., 1984, MODIFIED SCALE ASSES
  • [2] [Anonymous], 1993, The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation
  • [3] Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
    Arnt, J
    Skarsfeldt, T
    [J]. NEUROPSYCHOPHARMACOLOGY, 1998, 18 (02) : 63 - 101
  • [4] Neuropsychological deficits associated with schizophrenic syndromes
    Baxter, RD
    Liddle, PF
    [J]. SCHIZOPHRENIA RESEARCH, 1998, 30 (03) : 239 - 249
  • [5] BUNNEY WE, 1963, ARCH GEN PSYCHIAT, V9, P280
  • [6] SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY WITH TC-99M-EXAMETAZIME IN UNMEDICATED SCHIZOPHRENIC-PATIENTS
    EBMEIER, KP
    BLACKWOOD, DHR
    MURRAY, C
    SOUZA, V
    WALKER, M
    DOUGALL, N
    MOFFOOT, APR
    OCARROLL, RE
    GOODWIN, GM
    [J]. BIOLOGICAL PSYCHIATRY, 1993, 33 (07) : 487 - 495
  • [7] CEREBRAL BLOOD-FLOW IN SCHIZOPHRENIA - EFFECTS OF MEMORY PROCESSING ON REGIONAL ACTIVATION
    GUR, RE
    JAGGI, JL
    SHTASEL, DL
    RAGLAND, JD
    GUR, RC
    [J]. BIOLOGICAL PSYCHIATRY, 1994, 35 (01) : 3 - 15
  • [8] Heaton R.K., 1981, MANUAL WISCONSIN CAR
  • [9] HIMMELHOCH S, 1996, BIOL PSYCHIAT, V39, P227
  • [10] SCHIZOPHRENIC SYNDROMES, COGNITIVE PERFORMANCE AND NEUROLOGICAL DYSFUNCTION
    LIDDLE, PF
    [J]. PSYCHOLOGICAL MEDICINE, 1987, 17 (01) : 49 - 57